Long-Term Liabilities: The sum of all non-current liabilities.
MapLight Therapeutics, Inc. (MPLT) had Long-Term Liabilities of $4.67M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-60.67M |
|
-- |
|
-- |
|
$64.50M |
|
$-64.50M |
|
$3.83M |
|
$-60.67M |
|
$-60.67M |
|
$-60.67M |
|
$-60.67M |
|
$-60.67M |
|
$-60.67M |
|
$-64.50M |
|
$-65.16M |
|
45.28M |
|
45.28M |
|
$-1.34 |
|
$-1.34 |
|
| Balance Sheet Financials | |
$327.23M |
|
$0.97M |
|
$91.56M |
|
$418.79M |
|
$14.28M |
|
-- |
|
|
Long-Term Liabilities |
$4.67M |
$18.95M |
|
$399.83M |
|
$399.83M |
|
$399.83M |
|
45.21M |
|
| Cash Flow Statement Financials | |
$-51.18M |
|
$67.01M |
|
$-6.85M |
|
$46.94M |
|
$55.91M |
|
$8.98M |
|
$9.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.17% |
|
-15.17% |
|
-14.49% |
|
-15.17% |
|
$8.84 |
|
$-1.13 |
|
$-1.13 |
|